findmyKOL

Richard Spaide, MD

Enriched profile

Clinical Associate Professor, Department of Ophthalmology, NYU Grossman School of Medicine · Vitreous Retina Macula Consultants of New York

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2021Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Richard Spaide is Clinical Associate Professor, Department of Ophthalmology, NYU Grossman School of Medicine at Vitreous Retina Macula Consultants of New York. OpenAlex indexes 566 publications with 46,557 citations (h-index 109); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Ophthalmology profiles in the findmyKOL directory.

Data verified 17 Oct 2026

Overview

Updated 18 Oct 2026

Richard Spaide, MD, is Clinical Associate Professor, Department of Ophthalmology, NYU Grossman School of Medicine at Vitreous Retina Macula Consultants of New York, P.C.. The public record shows 566 publications with 46,557 citations (h-index 109), centered on Retinal Diseases and Treatments, Ocular Diseases and Behçet’s Syndrome, Retinal and Optic Conditions. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 22 companies.

  • Top research focus: Retinal Diseases and Treatments
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 22 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Macular Degeneration (AMD)1 trialRetinal Vein Occlusion1 trialCentral Serous Chorioretinopathy1 trialChoroidal Neovascularization1 trial

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal and Optic ConditionsRetinal and Macular SurgeryRetinal Imaging and Analysis

Drugs & molecules

across trials, industry payments and publications
Vabysmogeneric · FaricimabClinical trials—Industry payments13Publications—Lucentisgeneric · RanibizumabClinical trials—Industry payments7Publications—Eyleageneric · AfliberceptClinical trials—Industry payments5Publications—Syfovregeneric · PegcetacoplanClinical trials—Industry payments3Publications—Xdemvygeneric · LotilanerClinical trials—Industry payments3Publications—Miebogeneric · PerfluorohexyloctaneClinical trials—Industry payments2Publications—VorolanibClinical trials—Industry payments2Publications—Xiidrageneric · LifitegrastClinical trials—Industry payments2Publications—Yutiqgeneric · FluocinoloneClinical trials—Industry payments2Publications—Beovugeneric · BrolucizumabClinical trials—Industry payments1Publications—Brilliant blue GClinical trials—Industry payments1Publications—Izervaygeneric · Avacincaptad pegolClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Topcon Medical Systems, Inc.Clinical trials—Industry payments25Topcon Healthcare, Inc.Clinical trials—Industry payments13Merck Sharp & Dohme LLCClinical trials—Industry payments12Janssen Global Services, LLCClinical trials—Industry payments10Genentech USA, Inc.Clinical trials—Industry payments9F. Hoffmann-La Roche AGClinical trials—Industry payments8Heidelberg Engineering, Inc.Clinical trials—Industry payments8Bausch & Lomb Americas Inc.Clinical trials—Industry payments6Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments5Vitreous -Retina- Macula Consultants of New YorkClinical trials4Industry payments—Alcon Research LLCClinical trials—Industry payments3Alcon Vision LLCClinical trials—Industry payments3Apellis Pharmaceuticals, Inc.Clinical trials—Industry payments3Tarsus Pharmaceuticals, Inc.Clinical trials—Industry payments3EyePoint Pharmaceuticals US, Inc.Clinical trials—Industry payments2Alimera Sciences, Inc.Clinical trials—Industry payments1Amgen Inc.Clinical trials—Industry payments1Astellas Pharma US IncClinical trials—Industry payments1Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments1Dutch Ophthalmic, USAClinical trials—Industry payments1Genentech, Inc.Clinical trials—Industry payments1Manhattan Eye, Ear & Throat HospitalClinical trials1Industry payments—Novartis Pharmaceuticals CorporationClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
566publications

Distinct works indexed by OpenAlex, matched via ORCID.

46,557citations

Total citations across indexed works.

109h-index

Hirsch index (OpenAlex). i10-index 331.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
22companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    99.3%
    Antineovascularisation agents98.6%
    Faricimab-svoa100%
    Part B, office-administered≥173 patients
    Vascular Endothelial Growth Factor Inhibitor0.3%
    Ranibizumab100%
    Part B, office-administered≥14 patients

    + 6 more classes in this area

  • Cancer & immunology

    0.6%
    Vascular Endothelial Growth Factor Inhibitor0.6%
    Aflibercept100%
    Part B, office-administered≥57 patients
  • Cardiovascular

    0%
    Beta blocker0%
    Timolol Maleate100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Lawrence A. Yannuzzi97K. Bailey Freund87Jason S. Slakter55John A. Sorenson45Christine A. Curcio36Yale L. Fisher35James M. Klancnik29Frank G. Holz26David R. Guyer20Yutaka Imamura19Hideki Koizumi18Sandrine Zweifel18Dennis A. Orlock18Giovanni Staurenghi16Steffen Schmitz-Valckenberg16Usha Chakravarthy15Michael J. Cooney15Mihoko Suzuki14Sarah Mrejen14Peter M. Maloca13Chui Ming Gemmy Cheung13Alan C. Bird13David Sarraf13Srinivas R. Sadda12Takamitsu Fujiwara12Tomohiro Iida12Adnan Tufail11Luiz H. Lima11Nadia K. Waheed11Gerardo Ledesma‐Gil11Kyoko Ohno‐Matsui11Ketan Laud11Chiara M. Eandi11Taku Sato10Hendrik P. N. Scholl10Jeffrey D. Messinger10Philip J. Rosenfeld10Francine Béhar‐Cohen9James G. Fujimoto9Sotaro Ooto9

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/richard-spaide-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/richard-spaide-b672011b7

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

Mentions by others

where others cite or feature them
  • Other

    retinahistory.asrs.org/video-interviews/richard-spaide

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →retinahistory.asrs.org ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    American Board of Ophthalmology

    1987
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
  • MD

    Sidney Kimmel Medical College at Thomas Jefferson University (formerly Jefferson Medical College)

    1981
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • BA/BS

    Muhlenberg College (undergraduate)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vrmny.com ↗
  • Ophthalmology Residency

    St. Vincent's Hospital and Medical Center, New York

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vrmny.com ↗
  • Vitreoretinal Surgical Fellowship

    Manhattan Eye, Ear & Throat Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vrmny.com ↗

Editorial & leadership roles

journal and society appointments
  • Past Executive Editor

    American Journal of Ophthalmology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vrmny.com ↗
  • Associate Editor

    Retina (journal)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vrmny.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.